Cytogenetics of Human Small Cell Lung Cancer
The combination of chemo- and radiotherapy has resulted in prolonged survival and potential cures in patients with some neoplastic diseases. Small cell lung cancer (SCLC) is one of those neoplasms in which over 90% of the patients respond favorably to treatment, about 10% being cured. However, patients with non-small-cell lung cancer (non-SCLC) have a much lower response rate to current therapeutic regimens. Therefore, accurate diagnosis is extremely important. With the advent of chromosome banding techniques in the early 1970s (Caspersson et al. 1968; Seabright 1971), it became possible to identify chromosomal abnormalities that were specific for certain neoplastic diseases, including the Philadelphia or Ph1 chromosome in chronic myelogenous leukemia (CML) (Nowell and Hungerford 1960), t(15;17) in acute progranulocytic leukemia (APL) (Rowley et al. 1977), t(8;14) in Burkitt’s lymphoma (Zech et al. 1976), t(14;18) in follicular lymphoma (Yunis et al. 1982), deletion 13q14 in retinoblastoma (Yunis and Ramsey 1978), deletion 11p14 in Wilm’s triad syndrome (Miller 1977), and deletion 6q in melanoma (Trent et al. 1983; Becher et al. 1983). Here we wish to describe a specific chromosomal marker, deletion (3)(p14–23), that is associated with and diagnostic of SCLC.
KeywordsSmall Cell Lung Cancer Herpes Simplex Virus Type Interstitial Deletion Continuous Cell Line Small Cell Lung Cancer Patient
Unable to display preview. Download preview PDF.
- Francke U, Francke BR (1979) Assignment of gene(s) required for herpes simplex virus Type I (HVIS) replication to the long arm of chromosome 11. Human gene mapping 5: fifth international workshop on human gene mapping. Birth Defects: Original Article Series XV: 11, 1979. The National Foundation, New York, p 550Google Scholar
- Luthardt FW (1982) In vitro induced expression of genomic “hot spot” at 3p14. (abstract) Abstract of the thirty-third annual meeting of the American Society of Human Genetics, p 134AGoogle Scholar
- Miller RW (1977) Cancer and congenital malformation: another view. In: Mulvihill JJ, Miller RW, Fraumeni JF Jr (eds) Genetics of human cancer. Raven, New York, p 81Google Scholar
- Paris Conference (1971) Standardization in human cytogenetics. Birth Defects: Original Article Series VIII 7 1972. The National Foundation, New YorkGoogle Scholar
- Shimosato Y, Kameya T, Hirohashi F (1979) Growth, morphology, and function of xenotrans planted human tumors. In: Sommers SC, Rosen PT (eds) Pathology annual, part 2. Appleton, New York, pp 215–257Google Scholar
- Whang-Peng J, Carney DN, Lee EC, Kao-Shan CS, Bunn PA, Gazdar A, Minna JD (1983) In: Crispin R (ed) Cancer: etiology and prevention. Elsevier, New York, pp 47–60Google Scholar